Evidence map›Paper›PMID 28351924›Full record

ArticlemBio2017

Kyle Jarrod McLean, Marcelo Jacobs-Lorena

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Microorganisms · 2022
    Article
  11. Review
  12. Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Molecular Mechanisms of Drug Resistance inAnnual review of microbiology · 2020
    Review
  18. Article
  19. Article
  20. Validation ofPeerJ · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kyle Jarrod McLeanDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Malaria Research Institute, Baltimore, Maryland, USA.
Marcelo Jacobs-LorenaDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Malaria Research Institute, Baltimore, Maryland, USA ljacob13@jhu.edu.
Johns Hopkins University · US

Funding

ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BELCHER, HAROLYN MILLICENT EDITH · 1985 to 2007
$37.3M
Genetic Analysis of Plasmodium falciparum Gametocyte FormationR21AI067640 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO · 2006 to 2007
$444k
NCRR NIH HHS M01 RR000052NIAID NIH HHS R21 AI067640
6 · The paper itself

Abstract

The target of rapamycin complex 1 (

Indexed as

Gene Expression RegulationAmino AcidsCell SurvivalDNA Transposable ElementsMutagenesis, InsertionalMutationPlasmodium falciparumProtozoan ProteinsRepressor ProteinsRNA Polymerase IIIAmino AcidsDNA Transposable ElementsProtozoan ProteinsRepressor ProteinsRNA Polymerase IIImalariaPlasmodiumTOR pathway

Identifiers

PMID28351924
PMCPMC5371417
OpenAlexW2599977247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.